 Home > Active Ingredient News > Endocrine System > Movement Disorders: Determinants of risk and progression of type 2 diabetes or Parkinson's disease

Movement Disorders: Determinants of risk and progression of type 2 diabetes or Parkinson's disease

 Last Update: 2021-03-21
 Source: Internet
 Author: User

Tags

infrared 6 2019

risk elimination

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Diabetes mellitus ( DM ) is considered by the World Health Organization ( WHO ) to be one of the four major non-communicable diseases.

Diabetes ( diabetes mellitus DM ) is the World Health Organization ( the WHO ) considered to be one of the four major non-communicable diseases.

Previous systematic reviews and meta-analysis have thoroughly explored the risk relationship between T2DM and PD , but the results are inconsistent.

In this study, the researchers searched 6 databases, including PubMed , Web of Science , Scopus , Ovid , bioRxiv and medRxiv , and collected 33,408 articles.

The results show that in the highest-quality prospective studies, T2DM has the most obvious impact on the development risk of PD , and there is some evidence that T2DM T2DM has the most obvious impact on the development risk of PD , and there is some evidence that T2DM T2DM has The impact of the development risk of PD is the most obvious, and there is some evidence that T2DM can accelerate cognitive decline.

2 diabetes and increased risk of developing Parkinson's disease-related

There is more and more evidence of sharing biology between T2DM and PD .

T2DM and PD T2DM and PD There is more and more evidence of sharing biology between T2DMandPD .

In short, the research results prove that the research results prove that T2DM not only affects the risk of PD , but also affects the progression of PD .

Original source

Harneek Chohan et al, onlinelibrary.

Harneek Chohan et al, onlinelibrary.
wiley.
com/doi/10.
1002/mds.
28551" target="_blank" rel="noopener">Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression , Movement Disorders (2021).
doi.
org/10.
1002/mds.
28551">DOI: 10.
1002/mds.
28551onlinelibrary.
wiley.
com/doi/10.
1002/mds.
28551" target="_blank" rel="noopener"> Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression doi.
org/10.
1002/mds.
28551">DOI: 10.
1002/mds.
28551 DOI: 10.
1002/mds.
28551 leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.